
Blockchain is moving toward definitive uses in clinical trials to enhance clinical supply capabilities, with the potential of enabling data ownership for patients.
Blockchain is moving toward definitive uses in clinical trials to enhance clinical supply capabilities, with the potential of enabling data ownership for patients.
Click the title above to open the Applied Clinical Trials November 2018 issue in an interactive PDF format.
October has offered a striking spectacle of contrasts in Europe's ponderous attempts to construct a comprehensive policy on health.
This article delves into the why, when, and how a patient-centric approach should be adopted for both the benefit of patients and the successful development of novel and innovative medicines.
What technologies ease clinical trial laboratory sample and data management, and what are the benefits?
Dr. Tshaka Cunningham, Associate Director of Scientific Collaboration for DIA, will discuss his perspectives on advancements in gene editing therapies and their impact on the industry.
Updated employee announcements, business news, awards, and recognition in the industry today.